Women in Science, Discovery and Medicine (WiSDoM) Committee
WiSDoM 2025 End-of-year Mixer
WiSDoM is a Sub-Faculty of Clinical and Molecular Medicine (SF-CaMM) committee designed to promote inclusive gender equity in medicine and research to women of all backgrounds and career stage. The committee was formed in August 2015 and launched the Women in Medicine and Science program at a forum on 10 August 2015. WiSDoM runs several events every year designed to bring together the women of SF-CaMM and harbour the sharing of strategies on how to succeed in the face of adversity.
Mission statement
To ensure SF-CaMM remains welcoming to all peoples, no matter who they are, where they come from or who they identify as. We will support their personal professional ambitions and provide advice and opportunities for achieving professional goals. This will be facilitated by networking, education and representation to the SF-CaMM Executive.
Terms of Reference
- To promulgate equal opportunity for women
- To provide mentorship and guidance on career advancement for women
- To promote a diverse and socially equitable workplace for women.
Meeting frequency: Quarterly
Recommended publications
- ‘Despair is not an option’ — how scientists can help protect federal research | By Gretchen T. Goldman, nature.com, 4 February 2025
- Misogyny in medicine impacts us all | By Associate Professor Ada Cheung, University of Melbourne
- How to Get More Women in Leadership Roles? Don’t Ask Them to Apply
- Shocking abuse Professor Catherine Bennett copped from Covid trolls | By news.com.au - Australia’s leading news site
- Gender-based discrimination in the NHMRC Investigator Grants Scheme
- Invisible Women: Exposing Data Bias in a World Designed for Men by Carine Criado Perez
- Adding Women to the C-Suite Changes How Companies Think
Useful links
Meet the WiSDoM team
Chair
 | Monash researcher and IVF clinician Professor Beverley Vollenhoven is improving the rate of successful pregnancies in older women and seeking new treatments for fibroids - a common condition, often treated by removing the womb. Find out more about Professor Beverley Vollenhoven |
Secretary
 | Ms Jin Leng Graham, Executive Officer, SF-CaMM. Contact Ms Jin Leng Graham. |
Current members
 | Professor Kate Loveland is recognised internationally for investigating the mechanisms that underpin testis development and sperm formation. Her discoveries include key molecular switches that regulate cell fate via the TGFbeta superfamily, Hedgehog and Wnt signaling pathways. Find out more about Professor Kate Loveland. |
 | Professor Megan Galbally is the Director of the Centre for Women’s and Children’s Mental Health. Her area of research focus is understanding the relationship between maternal mental health and child mental health and developmental outcomes. Her research interests also include early women's mental health and models of antenatal care for women with Eating Disorders, Schizophrenia and Bipolar Disorder. Find out more about Professor Megan Galbally. |
 | Dr Jun Yang is a Senior Postdoctoral Fellow within the Cardiovascular Endocrinology Group at Hudson Institute and a Consultant Endocrinologist at Monash Health. Since graduating with a MBBS (Hons, rank number 1) from Monash University, she has been actively involved in basic and clinical research as well as clinical practice. Find out more about Dr Jun Yang. |
 | Dr Shayanti Mukherjee is the Head of Translational Tissue Engineering which focuses on Women’s health, specifically in addressing the inadequacies in biomaterials for reconstructive surgery for disorders such as pelvic organ prolapse (POP). Find out more about Dr Shayanti Mukherjee. |
 | Dr Harriet Fitzgerald is a Research Fellow in the Department of Obstetric and Gynaecology. Find out more about Dr Harriet Fitzgerald. |
 | Dr Vanalysa Ly (Vann) is the School of of Clinical Sciences at Monash Health Research Manager. Contact Dr Vanalysa Ly |